Alcon Strengthens Surgical Glaucoma Portfolio With $475M Ivantis Deal
Alcon AG (NYSE:ALC) has agreed to acquire Ivantis Inc for $475 million. Alcon may be required to make additional contingent payments upon…
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Oppenheimer Initiates Coverage On Alcon with Perform Rating
Oppenheimer analyst Steven Lichtman initiates coverage on Alcon (NYSE:ALC) with a Perform rating.
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 15)
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 14)
Where Alcon Stands With Analysts
Within the last quarter, Alcon (NYSE:ALC) has observed the following analyst ratings:
Wells Fargo Maintains Overweight on Alcon, Raises Price Target to $93
Wells Fargo analyst Larry Biegelsen maintains Alcon (NYSE:ALC) with a Overweight and raises the price target from $90 to $93.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 95 companies made new 52-week highs.